ArriVent Biopharma
Total Funding
$155 Million
Total Rounds
1
First Raise
Mar 27, 2023
Latest Raise
Mar 27, 2023
Organization Chart
Founders and leadership hierarchy for this company.
Contact details require Sales or Enterprise
All Funding Rounds
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 3/27/2023 | Series B | $155 Million | Sofinnova Investments, General Catalyst |
Company Performance Metrics
Premium Feature
Upgrade to Premium to view Capital Momentum Score and performance metrics